In summary, as depicted in Fig. 9, this study demonstrated that the downregulation of PDLIM2 leads to heightened NF-κB activity in lung cancer cells, thereby dysregulating SDH gene expression and mitochondrial functions. The gene discussed is SDHB; the disease is lung cancer.